This review systematically synthesizes the mechanistic role of AMPK in NAFLD pathogenesis and the regulatory effects of TCM-derived natural products, aiming to provide a theoretical framework for developing novel therapeutics (Figure 1). This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.